Altertox

Posts by author

Aurelia

Partnership between the French Society of Toxicology and Altertox Academy

The French Society of Toxicology (SFT) and Altertox Academy (ex-CAAT Academy) have reached an agreement in regard to the Altertox Academy laboratory trainings for the period between 2018 and 2019. With this official partnership, the SFT acknowledges that trainings developed under Altertox Academy provide valuable toxicological insights for continuing professional development and a participation at the same…
Read More

Simcyp

Physiologically-Based Pharmacokinetic Modelling in Virtual Human Populations and Preclinical Species. Monday 16th October, 2017 – Simcyp (a Certara® company) Certara® is the leading provider of decision support technologies and consulting services for optimizing drug development and improving both health, and safety outcomes. Simcyp (a Certara® company) develops and provides mechanistic, physiologically-based pharmacokinetic (PBPK) modelling services…
Read More

Human telomerized cells

Relevant and standardizable in vitro test systems Friday 29th September, 2017, Regina Grillari & Matthias Wieser from Evercyte GmbH Evercyte, an innovative biotechnology spin-out company from the University of Natural Resources and Life Sciences Vienna, is focused on the establishment of human cell cultures that fulfill all conditions for the performance of state-of-the-art toxicity studies,…
Read More

TissUse: “Multi-Organ-Chip” platform

Wednesday 27th September, 2017 - TissUse TissUse is a vibrant Berlin, Germany-based, growth company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissue. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological…
Read More

KU Leuven Drug Delivery and Disposition Lab

In vitro models for hepatic drug handling and drug-induced cholestasis Tuesday 25th June, 2017 - Pieter Annaert & the hepatic drug disposition group at the KU Leuven The hepatic drug disposition group at the KU Leuven Drug Delivery and Disposition Lab has many years of experience in the development and application of in vitro models…
Read More

GARD Skin Sensitization Test

Next generation safety testing for sensitisation assessment of chemicals Friday 19th May, 2017 - Henrik Johansson & Hanna Frykman At SenzaGen we do in vitro testing for chemical risk assessment. Using the latest technology, we have developed the next generation safety testing for sensitisation assessment of chemicals. Join us a the CAAT Academy training in…
Read More

Human Primary Hepatocyte Production: HepaRG

Biopredic international is an innovative biotechnology SME based in France, focused on providing cells and tissues as tools for drug discovery and development. Liver related products are one of the expertise areas of the company Biopredic International & The HepaRG stem cell line Biopredic International has established an extensive network of liver tissue acquisition which is…
Read More